Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian N Ramos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Methods & Clinical Development|January 8, 2020
Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult <i>mdx</i> MiceBuel D Rodgers, Yemeserach Bishaw, Denali Kagel, et al.
Current Gene Therapy|April 27, 2012
Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectorsJane T Seto, Julian N Ramos, Lindsey Muir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2015
Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cellsAndrea Lh Arnett, Patryk Konieczny, Julian N Ramos, et al.
Human Molecular Genetics|May 8, 2016
Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophyMichelle Wehling-Henricks, Zhenzhi Li, Catherine Lindsey, et al.
Analytical Biochemistry|November 9, 2024
Optimization of a high throughput screening platform to identify inhibitors of asymmetric diadenosine polyphosphatasesDavid N Frick, Mujidat Shittu, Chase R Bock, et al.
Progress in Molecular Biology and Translational Science|December 6, 2011
Animal models of muscular dystrophyRainer Ng, Glen B Banks, John K Hall, et al.
Nature Biotechnology|January 29, 2025
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusionJae-Jun Kim, Simone N T Kurial, Pervinder K Choksi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Methods & Clinical Development|January 8, 2020
Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult <i>mdx</i> MiceBuel D Rodgers, Yemeserach Bishaw, Denali Kagel, et al.
Current Gene Therapy|April 27, 2012
Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectorsJane T Seto, Julian N Ramos, Lindsey Muir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2015
Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cellsAndrea Lh Arnett, Patryk Konieczny, Julian N Ramos, et al.
Human Molecular Genetics|May 8, 2016
Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophyMichelle Wehling-Henricks, Zhenzhi Li, Catherine Lindsey, et al.
Analytical Biochemistry|November 9, 2024
Optimization of a high throughput screening platform to identify inhibitors of asymmetric diadenosine polyphosphatasesDavid N Frick, Mujidat Shittu, Chase R Bock, et al.
Progress in Molecular Biology and Translational Science|December 6, 2011
Animal models of muscular dystrophyRainer Ng, Glen B Banks, John K Hall, et al.
Nature Biotechnology|January 29, 2025
AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusionJae-Jun Kim, Simone N T Kurial, Pervinder K Choksi, et al.
Pageof 1